Rational design of dual ALK inhibitors: scaffolds and strategies to circumvent drug resistance

Bioorganic Chemistry 2026

View at publisher
Authors: Tawfeek A.A. Yahya, Mustafa A. Al-Qadhi
DOI: 10.1016/j.bioorg.2026.109706
Cited by: 2
References: 174

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Melanoma and MAPK Pathways HER2/EGFR in Cancer Research

Publication details

Journal / source
Bioorganic Chemistry
Publisher
Elsevier BV
Volume
174
Pages
109706–109706
Publication date
26 February 2026
Language
EN